Egholm Michael bought LAB
March 20, 2026 · Form 4 insider transaction
Egholm Michael bought 1,042,373 shares of Standard BioTools Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 19 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,042,373
Price
$0.00
Total value
N/A
InsiderEgholm Michael
RoleOfficer, Director
CompanyStandard BioTools Inc. (LAB)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 20, 2026
Filing dateApril 8, 2026
Shares owned after6,594,083
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.